Star Therapeutics logo

Star Therapeutics

Recent Finacing

Series C

Recent Raise

$90M


Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.

Total Funding

$190M

Headquarters

South San Francisco, USA

Founded

N/A

Focus Areas

Biotechnology
Antibody Therapies
Hematology/Immunology

Investors